实用肿瘤杂志2024，Vol.39Issue(3)：209-218,10.DOI:10.13267/j.cnki.syzlzz.2024.033
肺癌内科治疗临床研究十年回顾和现状
Clinical trials in medical treatent of lung cancer:a ten-year review and current landscape
陈薪如 1周彩存2
作者信息
- 1. 同济大学附属上海市肺科医院肿瘤科,上海 200433
- 2. 同济大学附属东方医院肿瘤科,上海 200123
- 折叠
摘要
Abstract
Lung cancer remains the leading cause of cancer-related death,posing a serious threat to human health.Over the past decade,with the advent of the era of precision medicine,the landscape of lung cancer treatment has dramatically changed.A series of clinical trials related to perioperative immunotherapy or targeted therapy help to cure early-stage non-small-cell lung cancer(NSCLC).The application of immunotherapy and targeted therapy provides opportunities for patients with advanced NSCLC to achieve long-term survival.Addition-ally,a variety of new drugs,such as antibody-drug conjugates(ADCs),immune bispecific antibodies,and tumor vaccines,are expected to enhance the anti-tumor effectiveness.This article reviews important clinical trials in the field of lung cancer medical treatment over the past decade and discusses future directions based on the current treatment landscape.关键词
肺癌/靶向治疗/免疫治疗Key words
lung cancer/targeted therapy/immunotherapy引用本文复制引用
陈薪如,周彩存..肺癌内科治疗临床研究十年回顾和现状[J].实用肿瘤杂志,2024,39(3):209-218,10.
